🦊/Companies

Encapsulate

Founded 2019 · 16 employees on LinkedIn · 2 known investors

Find your way into Encapsulate

307 people in our graph share verified history with the Encapsulate team — schools, employers, funds. One of them is your warm intro.

Madison Lenormandunlockedknows Leila Daneshmandi · together at UConn Health (overlapped)
knows the team · via Amirkabir University of Technology - Tehran Polytechnic
×5knows the team · via University of Connecticut
×5knows the team · via Oklahoma State University

Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.

Founders & leadership

Encapsulate was founded in 2019 by Armin Rad, Leila Daneshmandi, and Armin Rad, Ph.D..

ARArmin Rad
Armin RadinCo-founder & CEOArmin Rad holds a PhD in Biomedical Engineering and has worked on encapsulation technologies, targeted drug delivery, tissue engineering, and medical device development before co-founding Encapsulate, which develops tumor-on-a-chip systems for personalized cancer treatment prediction.
LDLeila Daneshmandi
Leila DaneshmandiinCo-founder & COOLeila Daneshmandi holds a Ph.D. in Biomedical Engineering and a Master's in Global Entrepreneurship from the University of Connecticut, where she serves as an Assistant Professor in Innovation and Entrepreneurship and founding director of the Entrepreneurship Hub. She is co-founder and COO of Encapsulate, a medical technology company developing automated tumor-on-a-chip systems for personalized cancer treatment.
ARArmin Rad, Ph.D.
Armin Rad, Ph.D.inCo-FounderArmin Rad holds a Ph.D. in Biomedical Engineering and founded Encapsulate after developing platforms for drug delivery to tumors, designing bone implants, engineering tissue constructs, and integrating semiconductors into medical devices.
BSBret Schipper
Bret SchipperinCMO
JS
John StrahleyinCFO

Investors · 2

Competitors · 1

by search overlap

Companies competing with Encapsulate for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2022$256K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Encapsulate do?
Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.
Who founded Encapsulate?
Encapsulate was founded by Armin Rad, Leila Daneshmandi, Armin Rad, Ph.D. in 2019.
Who are Encapsulate's investors?
Encapsulate's investors include Ambit Health Ventures, Connecticut Innovations.